ADAR and cancer: Overall, the sustained activation of the dsRNA sensor pathway following ADAR1 deletion reduces cancer cell viability, as demonstrated by the application of anti-cancer epigenetic inhibitors capable of inducing the transcription of repetitive sequences that form dsRNAs [29, 114] (Fig. 4C).